This review provides an update on the clinical features, natural history, and risk stratification of Brugada syndrome.
May inform Brugada syndrome risk stratification; leaves open prospective validation before practice change.
Brugada syndrome is a clinical entity characterized by type‐1 (coved) ST‐segment elevation in the right precordial electrocardiographic leads (V1–V3) and an aborted sudden cardiac death due to ventricular fibrillation (VF) in the absence of structural heart disease. Since 1992, when Brugada and Brugada reported the first case, numerous studies across the world have characterized the clinical, electrocardiographic, electrophysiologic, and prognostic features of Brugada syndrome. Several multicenter studies also suggested the natural history and proposed the risk stratification for subsequent cardiac events. In this review article, the clinical features of Brugada syndrome will be updated.
No takes yet. Share an insight, caveat, or question.
Wataru Shimizu (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: